About Women's Cancer Research Foundation
"Dedicated to improving cure rates for women with ovarian, endometrial, cervical and other gynecologic cancers." Women's Cancer Research Foundation (WCRF) in Newport Beach, CA prides in having 90% of each donation go into the actual research with only 10% overhead to maintain the facility. In 2018, WCRF's patient cure rates were higher than the national average (Source: Hoag Hospital 2017 Cancer Center Report)."
Clinical Trials at Women's Cancer Research Foundation
During the past decade, Women's Cancer Research Foundation conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Women's Cancer Research Foundation"
#1 collaborator was "Akesobio Australia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Women's Cancer Research Foundation
According to Clinical.Site data, the most researched conditions in "Women's Cancer Research Foundation" are
"Metastatic Cervical Cancer" (1 trials), "Ovarian Cancer" (1 trials), "Ovarian Neoplasms" (1 trials), "Platinum Sensitive Ovarian Cancer" (1 trials) and "Recurrent Cervical Cancer" (1 trials). Many other conditions were trialed in "Women's Cancer Research Foundation" in a lesser frequency.
Clinical Trials Intervention Types at Women's Cancer Research Foundation
Most popular intervention types in "Women's Cancer Research Foundation" are "Biological" (2 trials) and "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "AK104" (1 trials), "Adjuvant (GM-CSF) Alone" (1 trials), "FRα peptide plus Adjuvant (GM-CSF)" (1 trials), "Liposomal Doxorubicin" (1 trials) and "Telcyta" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Women's Cancer Research Foundation
The vast majority of trials in "Women's Cancer Research Foundation" are
3 trials for "Female" genders.
Clinical Trials Status at Women's Cancer Research Foundation
Currently, there are NaN active trials in "Women's Cancer Research Foundation".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Women's Cancer Research Foundation,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Women's Cancer Research Foundation, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".